Vouliez-vous dire
antibodies

Résultats de la recherche - 496 results

Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol

Publication Type: Peer reviewed scientific article Authors: Niels Adriaenssens; Beatrice Scholtes; Bruyndonckx, Robin; Jan Y Verbakel; An De Sutter; Stefan Heytens; Ann Van Den Bruel; I Desombere; Van Damme, Pierre; Goossens, Herman; Laëtitia Buret; Els D ...

Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up

Publication Type: Peer reviewed scientific article Authors: Niels Adriaenssens; Beatrice Scholtes; Bruyndonckx, Robin; Pauline Van Ngoc; Jan Yvan Jos Verbakel; An De Sutter; Stefan Heytens; Ann Van Den Bruel; I Desombere; Van Damme, Pierre; Goossens, Herm ...

Prevalence and incidence of anti-SARS-CoV-2 antibodies among healthcare workers in Belgian hospitals before vaccination: a prospective cohort studyObjectivesDesignSettingParticipantsOutcome measuresResultsConclusionsTrial registration number

Publication Type: Peer reviewed scientific article Authors: Laure Mortgat; Kristien Verdonck; Veronik Hutse; Isabelle Thomas; Cyril Barbezange; Heyndrickx, Leo; Nathalie Fischer; Vuylsteke, Bea; Ines Kabouche; Ariën, Kevin K; I Desombere; Els Duysburgh So ...

Comparison of Serological Methods for Tick-Borne Encephalitis Virus-Specific Antibody Detection in Wild Boar and Sheep: Impact of the Screening Approach on the Estimated Seroprevalence

Publication Type: Peer reviewed scientific article Authors: Trozzi, Gabrielle; Nadjah Radia Adjadj; Vervaeke, Muriel; Matthijs, Severine; Sohier, Charlotte; De Regge, Nick Source: Viruses, Volume 15, Issue 2 (2023) Manuscript versions:  Full text access:  ...

Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial

comparable antibody responses to the full dose in people <55 years. Here, we report the safety and immunogenicity of a fractional dose regimen of the BNT162 b2 vaccine. REDU- VAC is a participant-blinded, ...

Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?

Source: Lancet Microbe, Volume 3, Issue 12 (2022) Keywords: Antibodies, Bacterial COVID-19 Humans Mycoplasma pneumoniae Pandemics Pneumonia, Mycoplasma Health Topics:  Acute respiratory tract infection ...

Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.

have decreased antibody responses upon vaccination targeting other viral antigens. OBJECTIVES: As real-world data on vaccine responsiveness, we assessed the prevalence of SARS-CoV-2 antibodies among ...

QR code

QR code for this page URL